On December 8, 2023, Mr. James Cullem was terminated as Chief Executive Officer of Allarity Therapeutics, Inc. (Company) and all other positions with the company and its subsidiaries. On December 8, 2023, Mr. Thomas Jensen, age 45, was appointed by the company?s Board of Directors as Chief Executive Officer. Since July 2022, Mr. Jensen has served as Senior Vice President, Investor Relations and was previously the Company?s Senior Vice President, Information Technology since July 2021.

Mr. Jensen has also served as Senior Vice President, Information Technology of Allarity Therapeutics A/S, the Company?s predecessor, since June 2020. Mr. Jensen previously served as the Chief Technology Officer of the Company?s predecessor from 2004 to June 2020. Mr. Jensen co-founded Allarity Therapeutics A/S in 2004.

Mr. Jensen also established and currently leads its laboratories in Denmark. Mr. Jensen is a current member of the Company?s Board of Directors.